Open Accessibility Menu
Hide

COVID-19 Studies

COVID-19 Immune Protection Study

Enrolling

A study to evaluate the presence of and the immune response to the SARS-Cov-2 virus, in healthy adults between 30 and 65 years. Our primary goal is to better understand how the immune system affects a person's response to the virus.

Seeking Healthy Adults for a COVID-19 Study

You may be eligible if you are:

• Between the ages of 30 to 64 years old

• Have not received the COVID-19 vaccine

• Have not had COVID-19 in the past

Benefits of participating:

• Payment of approximately $250 to $400

• Free weekly COVID-19 self-testing at home with a comfortable nasal swab

Participant Details:

Follow the website below to complete a screening questionnaire. Once eligibility is determined, you will be contacted to schedule a visit at the Research Center for a blood draw. Participants will be asked to complete weekly electronic surveys and self-collected nasal swabs.

Corvus III

Enrollment Complete

Corvus III was conducted among hospitalized patients with mild to moderate symptoms of COVID-19. This study determines the effectiveness of an investigational medication vs. placebo among participants 18 years and older with a confirmed positive COVID test.

Primary Investigator: Dr. Jorge Robles

You may be eligible if you are:

  • Confirmed positive for COVID-19
  • Hospitalized with mild to moderate COVID-19 symptoms
  • Have adequate organ function
  • Do not meet exclusion criteria

Benefits of participating:

  • The opportunity to play an active role in your own healthcare
  • Compensation for participation
  • The knowledge that you are helping others

Participant Details:

Participants will have additional laboratory testing done before, during, and after a study medication or placebo is given. Participants will have follow up laboratory testing at the Research Center after discharge from hospital.

For more information visit: https://clinicaltrials.gov/ct2/show/NCT04734873

AstraZeneca COVID-19 Vaccine Trial

Enrollment Complete

A clinical study to evaluate an investigational vaccine for the prevention of COVID-19 in adults. The study will see how safe the investigational vaccine is and how well it works.

Primary Investigator: Dr. Christian Tomaszewski/Sub-Investigator: Dr. Allan Wu and Dr. Shiloh Williams

You may be eligible if you are:

  • Are 18 years of age or older
  • Are in good or stable health (you may have an underlying medical condition and still take part, if your disease is stable)
  • Have an increased risk of getting COVID-19
  • Do not have a previously confirmed diagnosis of COVID-19

Benefits of participating:

  • The study injections and study-related tests will be provided at no cost to you
  • A team of doctors and nurses will monitor your health carefully during the study
  • You will not be paid to take part in this study, but you may be reimbursed for reasonable travel costs during your participation.

Participant Details:

  • Participants will receive 2 doses of either AstraZeneca investigational vaccine or placebo injection
  • Blood draws and nasal swab specimens are required
  • Weekly electronic COVID-19 symptom surveys and frequent communication with Research Center staff
  • Follow-up period of 2 years including, 5 visits to the Research Center.

For more information visit:

https://clinicaltrials.gov/ct2/show/NCT04516746